文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜与开腹肝切除的成本效益:倾向性评分匹配920例单中心分析

Cost-Effectiveness of Laparoscopic vs Open Liver Resection: A Propensity Score-Matched Single-Center Analysis of 920 Cases.
PubMed 文献 · J Am Coll Surg · 2025-07-16

该回顾性研究纳入2017至2023年920例择期肝切除患者,经倾向性评分匹配比较腹腔镜(LLR)与开腹(OLR)肝切除的临床与经济结局。匹配后LLR在输血、术后住院时间、再入院、再手术及主要并发症方面均优于OLR,且总费用显著降低;成本效益分析显示LLR为优势策略,在愿意支付阈值25000美元下增量成本效益比为负值(-$2,120.72),净货币效益增加($75,015.92),成本效益概率达99.8%。

要点

  • 匹配后LLR全肝切除及大范围肝切除术后输血更少(p<0.001;p=0.001)。
  • LLR缩短术后中位住院时间并降低30天再入院、再手术及主要并发症率。
  • LLR总费用更低,成本效益分析显示其为优势策略,成本效益概率99.8%。

核心结论

  • LLR是安全且成本效益优于OLR的替代方案,其较高的初始手术费用被术后主要并发症、住院时间和总费用的显著降低所抵消。

研究设计与样本

  • 回顾性单中心研究,纳入2017至2023年920例连续择期肝切除患者,采用倾向性评分匹配比较LLR与OLR,并建立决策模型评估成本效益。

主要发现

  • 匹配后LLR在全肝切除中术后输血显著更少(p<0.001),大范围肝切除中亦显著更少(p=0.001)。
  • 匹配后LLR术后中位住院时间更短(p<0.001),30天再入院率(p=0.022)和再手术率(p=0.044)更低。
  • 匹配后LLR全肝切除术后肺炎(p=0.038)、非计划插管(p=0.020)、脓毒症(p=0.041)和主要并发症(p<0.001)显著减少。
  • LLR总费用在全肝切除(p<0.001)、小范围肝切除(p=0.001)和大范围肝切除(p<0.001)中均显著降低。
  • 成本效益分析显示LLR为优势策略,增量成本效益比为-$2,120.72,在愿意支付阈值25000美元下净货币效益增加$75,015.92,成本效益概率99.8%。

关键数值与推荐

  • 在愿意支付阈值25000美元下,LLR的增量成本效益比为-$2,120.72,净货币效益增加$75,015.92。
  • LLR在不同愿意支付阈值下具有成本效益的概率为99.8%。

临床怎么用

  • 对于适合的择期肝切除患者,LLR可作为OLR的安全且具成本效益的替代方案,尽管初始手术费用较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study compared the clinical and economic outcomes of laparoscopic (LLR) and open liver resection (OLR) for all hepatectomies, including minor and major hepatectomy. STUDY DESIGN: This retrospective study included 920 consecutive elective patients undergoing liver resection from 2017 to 2023. Patient demographics, postoperative surgical outcomes, postoperative length of stay (LOS), and cost were compared between LLR and OLR before and after propensity score matching (PSM). A decision model was developed to assess the cost-effectiveness of LLR vs OLR. RESULTS: After PSM, LLR was associated with significantly fewer postoperative transfusions for all hepatectomies (p < 0.001) and major hepatectomy (p = 0.001). LLR was associated with a shorter postoperative median LOS (p < 0.001), lower 30-day readmission (p = 0.022) and reoperation (p = 0.044) rate, and significantly reduced postoperative pneumonia (p = 0.038), unplanned intubation (p = 0.020), sepsis (p = 0.041), and major complication (p < 0.001) for all hepatectomies. This clinical superiority was complemented by a significant reduction in total cost for all (p < 0.001), minor (p = 0.001), and major (p < 0.001) hepatectomy. Cost-effectiveness analysis revealed that LLR was dominant over OLR, with a negative incremental cost-effectiveness ratio (-$2,120.72) and an increased net monetary benefit ($75,015.92) at the willingness-to-pay threshold of $25,000. The probability of LLR being cost-effective was 99.8% across various willingness-to-pay thresholds. CONCLUSIONS: LLR is a safe and cost-effective alternative to OLR. Although LLR has higher initial procedural costs, these are offset by significant reduction in postoperative major complication, LOS, and total cost.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Koh YX, Zhao Y, Tan IE, et al. Cost-Effectiveness of Laparoscopic vs Open Liver Resection: A Propensity Score-Matched Single-Center Analysis of 920 Cases. J Am Coll Surg. 2025. PMID: 39620602. doi:10.1097/XCS.0000000000001250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。